Sars Test Panel

HBV Multi-5 Test Panel

HBV5Panel-260 Panel 20panels/box
EUR 0.57

Human IgG antibody Laboratories manufactures the sars test panel reagents distributed by Genprice. The Sars Test Panel reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: Test Group: Panel

Human Tuberculosis IgG (TB IgG) Rapid Test Kit

100 µl
EUR 225

Human Tuberculosis IgG (TB IgG) Rapid Test Kit

1 ml Ask for price

Human Tuberculosis IgG (TB IgG) Rapid Test Kit

200 µl
EUR 350

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

100 µl
EUR 225

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

1 ml Ask for price

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

200 µl
EUR 350

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

100 µl
EUR 225

Panel information

Accu-Tell COVID-19 IgG/IgM Rapid Test

GEN-B352-40tests 40 tests
EUR 385.2
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

Single Donor Human Panel Tested Plasma

IPLASPT100ML each
EUR 584
Description: Single Donor Human Panel Tested Plasma

Single Donor Human Panel Tested Plasma

IPLASPT50ML each
EUR 300
Description: Single Donor Human Panel Tested Plasma

Single Donor Human Panel Tested Plasma

IPLASPT5ML each
EUR 198
Description: Single Donor Human Panel Tested Plasma

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-100g 100 µg
EUR 1525

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-20g 20 µg
EUR 187.5

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-50g 50 µg
EUR 337.5

Mouse SARS-CoV-2 Variants Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay)

FCM-B02R 96tests
EUR 1187.7
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a multiplex serological test for assessing antibody responses to mutant strains is in urgent need.

SARS-CoV-2 Variants Neutralizing Antibody 6-plex Panel (Flow Cytometry Multiplex Bead Assay)

FCM-N04R 96tests
EUR 1187.7
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a multiplex serological test for assessing antibody responses to mutant strains is in urgent need.

SARS-CoV-2 Omicron Sublineages Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay)

FCM-B18R 96tests
EUR 1187.7
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need.

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-100l 100 µl
EUR 650

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-1ml 1 ml
EUR 10500

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-200l 200 µl
EUR 2100

SARS-CoV-2 Variants Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay, Non-premixed)

FCM-B08R 96tests
EUR 1187.7
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a multiplex serological test for assessing antibody responses to mutant strains is in urgent need.

Mouse SARS-CoV-2 Omicron Subvariants Total IgG 5-plex Panel (Flow Cytometry Multiplex Bead Assay)

FCM-B07R 96tests
EUR 1187.7
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide. Omicron is a variant of SARS-CoV-2 first detected in November 2021 and is causing the ongoing COVID-19 pandemic. The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. Its recent descendants BA.2.12.1 and BA.4/5 have surged dramatically to become dominant in the United States and South Africa, respectively. BA.2.12.1 and BA.4/BA.5 exhibit comparable ACE2-binding affinities to BA.2. Importantly, BA.2.12.1 and BA.4/BA.5 display stronger neutralization evasion than BA.2 against the plasma from 3-dose vaccination and, most strikingly, from post-vaccination BA.1 infections.

Human SARS-CoV-2 Omicron Subvariants Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay)

FCM-B09R 96tests
EUR 1187.7
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide. Omicron is a variant of SARS-CoV-2 first detected in November 2021 and is causing the ongoing COVID-19 pandemic. The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. Its recent descendants BA.2.12.1 and BA.4/5 have surged dramatically to become dominant in the United States and South Africa, respectively. BA.2.12.1 and BA.4/BA.5 exhibit comparable ACE2-binding affinities to BA.2. Importantly, BA.2.12.1 and BA.4/BA.5 display stronger neutralization evasion than BA.2 against the plasma from 3-dose vaccination and, most strikingly, from post-vaccination BA.1 infections.Omicron BA.2.75 (a sub-variant of the BA.2 lineage) appears more transmissible than BA.5 in India and Nepal. Moreover, the World Health Organization (WHO) has lately classified BA.2.75 as a variant of concern lineages under monitoring (VOC-LUM).

Mouse SARS-CoV-2 Omicron Sublineages Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay)

FCM-B19R 96tests
EUR 1187.7
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need.